Monoclonal anti-D for immunoprophylaxis

Vox Sanguinis

Volumn 81, Issue 4, 2001, Pages 213-218

  Scott, Marion L ^a  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

Anti D; HDN; Monoclonal; Prophylaxis

Indexed keywords

MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; RHESUS D ANTIBODY; RHESUS D ANTIGEN; ALLOANTIBODY; DIAGNOSTIC AGENT; RHO(D) ANTIBODY;

ANTIGEN SPECIFICITY; B LYMPHOCYTE; BIOTECHNOLOGY; BLOOD GROUP INCOMPATIBILITY; DRUG SAFETY; EPSTEIN BARR VIRUS; ERYTHROCYTE; HALF LIFE TIME; HUMAN; IMMUNOPROPHYLAXIS; PRENATAL CARE; PRIORITY JOURNAL; PUERPERIUM; REVIEW; RHESUS INCOMPATIBILITY; VIRUS CELL TRANSFORMATION; BIOSYNTHESIS; BLOOD GROUP RHESUS SYSTEM; DRUG CONTROL; FEMALE; IMMUNOLOGY; MALE; PREGNANCY; RHESUS ISOIMMUNIZATION;

ANTIBODIES, MONOCLONAL; DRUG AND NARCOTIC CONTROL; FEMALE; HUMANS; ISOANTIBODIES; MALE; PREGNANCY; RH ISOIMMUNIZATION; RH-HR BLOOD-GROUP SYSTEM;

EID: 0035524690     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1423-0410.2001.00116.x     Document Type: Review

References (35)

1. Bowman JM: RhD haemolytic disease of the newborn. N Engl J Med 1998; 339:1775-1777
2. Stern K, Goodman HS, Berger M: Experimental isoimmunisation to hemo-antigens in man. J Immunol 1961; 87:189-198
3. Bowman JM: The prevention of Rh immunization. Transfus Med Rev 1988; 2:129-150
4. Crowther C, Middleton P: Anti-D administration after childbirth for preventing Rhesus alloimmunisation. Cochrane Database Syst Rev 2000; 2:CD000021
5. Bowman JM, Pollock JM: Failures of intravenous Rh immunoglobulin prophylaxis: an analysis of the reasons for such failures. Tranfus Med Rev 1987; 1:102-112
6. Crowther CA, Keirse MJ: Anti-D administration in pregnancy for preventing rhesus allo-immunisation. Cochrane Database Syst Rev 2000; 2:CD000020
7. Smith DB, Lawlor E, Power J, O'Roirdan J, McAllister J, Lycett C, Davidson F, Pathirana S, Garson JA, Tedder RS, Yap PL, Simmonds P: A second outbreak of hepatitis C virus infection from anti-D immunoglobulin in Ireland. Vox Sang 1999; 76:175-180
8. Perea WS, Moss MT, Urbaniak SJ: V(D)J germline gene repertoire analysis of monoclonal D antibodies and the implications for D epitope specificity. Transfusion 2000; 40:846-855
9. Steinitz M, Klein G, Koskimies S, Makel O: EB virus-induced B lymphocyte cell lines producing specific antibody. Nature 1977; 269:420-423
10. Kumpel BM, Poole GD, Bradley BA: Human monoclonal anti-D antibodies. Their production, serology, quantitation, and potential use as blood grouping reagents. Br J Haematol 1989; 71:125-129
11. Bron D, Feinberg MB, Nelson NHT, Kaplan HS: Production of human monoclonal IgG antibodies against Rhesus (D) antigen. Proc Natl Acad Sci USA 1984; 81:3214-3218
12. Thompson KM, Melamed MD, Eagle K, Gorick BD, Gibson T, Holbum AM, Hughes-Jones NC: Production of human monoclonal IgG and IgM antibodies with anti-D rhesus specificity using heterohybridomas. Immunology 1986; 58:157-160
13. Hughes-Jones NC, Gorick BD, Bye JM, Finnem R, Scott ML, Voak D, Marks JD, Ouwehand WH: Characterisation of human blood group scFv antibodies derived from a V gene phage-display library. Br J Haematol 1994; 88:180-186
14. Miescher S, Zahn-Zabal M, de Jesus M, Moudry R, Fisch I, Vogel M, Kobr M, Imboden MA, Kragten E, Bichler J, Mermod N, Stadler BM, Amstutz H, Wurm F: CHO expression of a novel human recombinant IgG1 anti-RhD antibody isolated by phage display. Br J Haematol 2000; 111:157-166
15. Klein P, B'eliard R, Glacet A, Moitel S, Ducrot T, Bourel D: Human recombinant anti-Rh (D) monoclonal antibodies. Human Antibodies 1997; 8:17-25
16. Armour KL, Clark MR, Hadley AG, Williamson LM: Human IgG molecules lacking FcgRI binding and monocyte triggering activities. Eur J Immunol 1999; 29:2613-2624
17. Edelman L, Margaritte C, Chaabihi H, Monchartre E, Blanchard D, Cardona A, Morin F, Dumas G, Petres S, Kaczorek M: Obtaining a functional recombinant anti-rhesus (D) antibody using the baculovirus-insect cell expression system. Immunology 1997; 91:13-19
18. Kumpel B, Elson CJ: Mechanism of anti-D mediated immune suppression - a paradox awaiting resolution? Trends Immunol 2001; 22:26-31
19. Tippett P: Co-ordinator's report on group 3: monoclonal Rh antibodies: serological and biological studies. Rev Francaise Transfus Immunohematol 1988; 31:249-258
20. Tippett P, Moore S: Monoclonal antibodies against Rh and Rh related antigens. J Immunogenet 1990; 17:309-319
21. Scott ML: Rh serology - Co-ordinator's report. Transfus Clin Biol 1996; 6:333-338
22. UKBTS/NIBSC: Guidelines for the Blood Transfusion Services in the United Kingdom, 4th edn. Norwich, UK, The Stationery Office, 2000
23. va. Br J Haematol 1990; 76:537-539
24. U population. Vox Sang 1990; 58:106-111
25. Wagner FF, Gassner C, Muller TH, Schonitzer D, Schunter F, Flegel WA: Three molecular structures cause Rhesus D category VI phenotypes with distinct immunohaematologic features. Blood 1998; 91:1-13
26. Hughes-Jones NC: The estimation of the concentration and equilibrium constant of anti-D. Immunology 1967; 12:565-571
27. Kumpel BM: Functional activity of human Rh monoclonal antibodies. J Immunogenet 1990; 17:321-330
28. Kumpel BM: An assessment of the functional activity of human Rh monoclonal antibodies after their evaluation by nine laboratories. Transfus Clin Biol 1996; 6:439-452
29. FDA: International Conference on Harmonisation: Guidance on viral safety evaluation of biotech nology products derived from cell lines of human or animal origin. Federal Register 1998; 63:51074-51084
30. Crawford DH, Azim T, Daniels GL, Huehns ER. Monoclonal antibodies to the Rh D antigen; in Cash JD (ed.): Progress in Transfusion Medicine, Vol. 3. Edinburgh, UK, Churchill Livingstone, 1988: 175-197
31. Goodrick MJ, Kumpel BM, Pamphilon DH, Fraser ID, Chapman GE, Dawes BJ, Anstee DJ: Plasma half lives and bioavailability of human monoclonal antibodies BRAD-3 and BRAD-5 following intramuscular injection into Rh D negative volunteers. Clin Exp Immunol 1994; 98:17-20
32. Kumpel BM, Goodrick MJ, Pamphilon DH, Fraser ID, Poole GD, Morse C, Stunned GR, Chapman GE, Thomas DP, Anstee DJ: Human Rh D monoclonal antibodies (BRAD-3 and BRAD-5) cause accelerated clearance of Rh D red blood cells and suppression of Rh D immunization in Rh D volunteers. Blood 1995; 86:1701-1709
33. Austin EB, Smith LC, Walker RE: An anti-idiotopic antibody-based enzyme linked immunosorbent assay for the quantification of the monoclonal anti-D BRAD-5. Vox Sang 2001; 80:179-183
34. Lloyd-Evans P, Kumpel BM, Bromelow I, Austin E, Taylor E: Use of a directly conjugated monoclonal anti-D (BRAD-3) for quantification of feto-maternal haemorrhage by flow cytometry. Transfusion 1996; 36:432-437
35. Thorpe S, Tumer CE, Heath AC, Sands D: A competitive enzyme linked immunoassay using erythrocytes fixed to microtitre plates for anti-D quantitation in immunoglobulin products. Vox Sang 2000; 79:100-107